# Stryker (SYK) revenue: $25.12B in 2025, 19-year history

URL: https://funkfolio.com/stock/SYK/revenue

> Stryker (SYK) revenue was $25.12B in fiscal 2025, up 11.2% from fiscal 2024. Over five fiscal years it grew 11.8% a year.

---

## Stryker (SYK) revenue

**Revenue · fiscal 2025:** $25.12B year ended Dec 31, 2025

Stryker (SYK) reported revenue of $25.12B in fiscal 2025 (the year ended December 31, 2025). That is 11.2% higher than the $22.60B of fiscal 2024. Figures as of 18 Nov 2026, 11:42 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Revenue, fiscal 2025:** $25.12B
- **Change on fiscal 2024:** +11.2%
- **Growth, 5 years:** +11.8% a year
- **Growth, 10 years:** +9.7% a year
- **Highest on record:** $25.12B fiscal 2025
- **Lowest on record:** $6.00B fiscal 2007
- **Fiscal years on record:** 19 2007–2025

Figures as of 18 Nov 2026, 11:42 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Stryker revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 11.8% a year; over ten years the rate was 9.7% a year. Across the 19 fiscal years on record (2007–2025), the highest was $25.12B in fiscal 2025 and the lowest $6.00B in fiscal 2007.

### Revenue by fiscal year

### Stryker revenue, year by year

Stryker (SYK) revenue by fiscal year

| Fiscal year | Revenue | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $25.12B | 11.2% up | Dec 31, 2025 |
| 2024 | $22.60B | 10.2% up | Dec 31, 2024 |
| 2023 | $20.50B | 11.1% up | Dec 31, 2023 |
| 2022 | $18.45B | 7.8% up | Dec 31, 2022 |
| 2021 | $17.11B | 19.2% up | Dec 31, 2021 |
| 2020 | $14.35B | 3.6% down | Dec 31, 2020 |
| 2019 | $14.88B | 9.4% up | Dec 31, 2019 |
| 2018 | $13.60B | 9.3% up | Dec 31, 2018 |
| 2017 | $12.44B | 9.9% up | Dec 31, 2017 |
| 2016 | $11.33B | 13.9% up | Dec 31, 2016 |
| 2015 | $9.95B | 2.8% up | Dec 31, 2015 |
| 2014 | $9.68B | 7.2% up | Dec 31, 2014 |
| 2013 | $9.02B | 4.2% up | Dec 31, 2013 |
| 2012 | $8.66B | 4.2% up | Dec 31, 2012 |
| 2011 | $8.31B | 13.5% up | Dec 31, 2011 |
| 2010 | $7.32B | 8.9% up | Dec 31, 2010 |
| 2009 | $6.72B | 0.1% up | Dec 31, 2009 |
| 2008 | $6.72B | 12.0% up | Dec 31, 2008 |
| 2007 | $6.00B | — | Dec 31, 2007 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

### How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

### Revenue at health care companies of similar size

Revenue of Stryker and comparable companies

| Company | Revenue | Fiscal year |
| --- | --- | --- |
| [Medtronic MDT](https://funkfolio.com/stock/MDT/revenue) | $36.36B | 2026 |
| [Bristol-Myers Squibb BMY](https://funkfolio.com/stock/BMY/revenue) | $48.20B | 2025 |
| Stryker SYK | $25.12B | 2025 |
| [McKesson MCK](https://funkfolio.com/stock/MCK/revenue) | $403.43B | 2026 |
| [Sanofi SNY](https://funkfolio.com/stock/SNY/revenue) | €46.72B | 2025 |
| [Moderna MRNA](https://funkfolio.com/stock/MRNA/revenue) | $1.92B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Stryker, figure by figure

- [Stryker market cap](https://funkfolio.com/stock/SYK/market-cap)
- [Stryker earnings](https://funkfolio.com/stock/SYK/earnings)
- [Stryker earnings per share (EPS)](https://funkfolio.com/stock/SYK/eps)
- [Stryker P/E ratio](https://funkfolio.com/stock/SYK/pe-ratio)
- [Stryker P/S ratio](https://funkfolio.com/stock/SYK/ps-ratio)
- [Stryker P/B ratio](https://funkfolio.com/stock/SYK/pb-ratio)
- [Stryker free cash flow](https://funkfolio.com/stock/SYK/free-cash-flow)
- [Stryker operating margin](https://funkfolio.com/stock/SYK/operating-margin)
- [Stryker dividend](https://funkfolio.com/stock/SYK/dividend)
- [Stryker shares outstanding](https://funkfolio.com/stock/SYK/shares-outstanding)
- [Stryker total debt](https://funkfolio.com/stock/SYK/total-debt)
- [Stryker cash on hand](https://funkfolio.com/stock/SYK/cash)
- [Stryker total assets](https://funkfolio.com/stock/SYK/total-assets)
- [Stryker return on equity (ROE)](https://funkfolio.com/stock/SYK/roe)
- [Stryker return on invested capital (ROIC)](https://funkfolio.com/stock/SYK/roic)

[Stryker (SYK) overview: price, valuation and scorecard](https://funkfolio.com/stock/SYK) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Stryker revenue: questions and answers

**What is Stryker's revenue?**

Stryker (SYK) reported revenue of $25.12B in fiscal 2025 (the year ended December 31, 2025). That is 11.2% higher than the $22.60B of fiscal 2024.

**What is the growth rate of Stryker's revenue?**

Over the five fiscal years to 2025 revenue grew at a compound 11.8% a year; over ten years the rate was 9.7% a year.

**What are the highest and lowest revenue figures on record for Stryker?**

Across the 19 fiscal years on record (2007–2025), the highest was $25.12B in fiscal 2025 and the lowest $6.00B in fiscal 2007.

**How is Stryker's revenue calculated?**

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Stryker it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: revenue

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Revenue vs earnings vs free cash flow: what each tells you](https://funkfolio.com/learn/stocks/revenue-earnings-free-cash-flow)

  Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Stryker (SYK) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/SYK/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.
